Dabrafenib - Novartis
At a glance
- Drug Originator GlaxoSmithKline
- Drug Licenced by BeiGene
- Drug Class Antineoplastics; Fluorobenzenes; Pyrimidines; Small molecules; Sulfonamides; Thiazoles
- Mechanism of Action Proto oncogene protein b raf inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 13
- NDAs 2
- International Patents 172
- Patent Applications 2,900
Table of Contents

Disclaimer